Abbott Laboratories logo

Abbott Laboratories (ABTCL)

Market Closed
1 Jun, 19:00
XSGO XSGO
108,200. 00
CLP
0
0%
CLP
- Market Cap
36.49 P/E Ratio
0.28% Div Yield
75 Volume
4.44 Eps
108,200 CLP
Previous Close
Add Transaction
Day Range
108,200 108,200
Year Range
77,020 119,500
Want to track ABTCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ABTCL closed Monday higher at 108,200 CLP, an increase of 0% from Friday's close, completing a monthly increase of 0% or 0 CLP. Over the past 12 months, ABTCL stock gained 0%.
ABTCL pays dividends to its shareholders, with the most recent payment made on May 15, 2026. The next estimated payment will be in In 2 months on Aug 15, 2026 for a total of 0.63 CLP.
The last earnings report, released on Apr 14, 2026, missed the consensus estimates by -1.2%. On average, the company has fell short of earnings expectations by -1.35%, based on the last three reports.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABTCL Chart

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock

ABT wins CE Mark for Libre Duo systems, the first dual glucose-ketone sensors, enabling real-time monitoring as European rollout begins later this year.

Zacks | 2 days ago
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Zacks | 5 days ago
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks | 6 days ago

Abbott Laboratories (ABTCL) FAQ

What is the stock price today?

The current price is 108,200.00 CLP.

On which exchange is it traded?

Abbott Laboratories is listed on XSGO.

What is its stock symbol?

The ticker symbol is ABTCL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.28%.

What is its market cap?

As of today, no market cap data is available.

Has Abbott Laboratories ever had a stock split?

Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.

Abbott Laboratories Profile

Pharmaceuticals Industry
Healthcare Sector
Robert Ford CEO
XSGO Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 May 2026 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100